Mortality Surveillance 1968-76: England and Wales

Changing digoxin potency and cardiac mortality in England and Wales 1968-76.

Data on monthly totals of cardiac deaths in England and Wales were examined in different ways to see whether there were any unexplained fluctuations in rates both at the time of an unplanned increase in the bioavailability and therefore the potency of the Lanoxin brand of digoxin in May 1972 and also when there was a coordinated increase in the bioavailability of other brands in October 1975. D...

Mortality from scleroderma in England and Wales 1968-1985.

Mortality data for scleroderma derived from death certificates from England and Wales for the years 1968-1985 were analysed. The overall crude mortalities were 0.9 and 3.8 per million per year in men and women respectively, which are similar to comparable data from the United States. There has been a small but statistically significant increase in mortality of 3% a year over this period, possib...

Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968-1998.

BACKGROUND The age standardised mortality rate per 100 000 population for all causes of liver tumours (International Classification of Disease 9 (ICD-9) 155) has almost doubled in England and Wales during the period 1979-1996. We further analysed the mortality statistics to determine which anatomical subcategories were involved. METHODS Mortality statistics for liver tumours of ICD-9 155, 156...

Legal abortion in England and Wales 1968--78.

Current differential infantile mortality, England and Wales.

A recent publication (Taylor, 1954) reviewed the decline of infantile mortality in England and Wales during the past half-century from a diagnostic viewpoint in as far as it is possible to do so by recourse to official sources. The outcome was a strong presumption in favour of the view that there is no likelihood ofstabilization atthe presentlevel, since the tempo of decline is still steep. One...